Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3′-untranslated region
Open Access
- 18 March 2008
- journal article
- Published by Springer Science and Business Media LLC in The Pharmacogenomics Journal
- Vol. 9 (2), 103-110
- https://doi.org/10.1038/tpj.2008.6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medicationPharmacogenetics and Genomics, 2007
- Rgs 2 gene polymorphisms as modulators of anxiety in humans?Journal of Neural Transmission, 2006
- A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overviewHuman Genetics, 2006
- Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in miceNature Genetics, 2004
- Safety and Efficacy of Long-Acting Risperidone in SchizophreniaPublished by Physicians Postgraduate Press, Inc ,2004
- RGS2 Binds Directly and Selectively to the M1 Muscarinic Acetylcholine Receptor Third Intracellular Loop to Modulate Gq/11α SignalingOnline Journal of Public Health Informatics, 2004
- A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype DataAmerican Journal of Human Genetics, 2003
- Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functionsJournal of Neurochemistry, 2003
- Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNANeuroscience Letters, 2001
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970